Size: 1809
Comment:
|
← Revision 74 as of 2021-06-21 20:48:17 ⇥
Size: 3558
Comment:
|
Deletions are marked like this. | Additions are marked like this. |
Line 1: | Line 1: |
#acl CscGroup:read,write,revert {{attachment:logobiostat.png|OICR_CSC Pathway and Network Analysis Logo Map Logo|align="right"}} <<BR>> |
#acl All:read |
Line 10: | Line 7: |
[[ChangjiangXu |ChangJiang Xu]], [[GaryBader | Gary Bader]] | [[ChangjiangXu |Changjiang Xu]], [[GaryBader | Gary Bader]] |
Line 14: | Line 11: |
* OICR CSC Projects (PI's name and/or project title listed below) * [[CancerStemCellProject/ChangjiangXu/LA02 | Laurie Ailles, Crosstalk between CAFs and ovarian cancer cells (LA02_CAF_ovarian_Laurie) ]] * [[CancerStemCellProject/VeroniqueVoisin/DIRKS | Peter Dirks]] |
* OICR CSC Projects: Biostatistical Part (PI's name and/or project title listed below) * Aaron Schimmer * [[CancerStemCellProject/ChangjiangXu/AS02 | AS02 (Some points in the reviewed paper to be addressed): Association between ClpP expression and known AML mutations]] * [[CancerStemCellProject/ChangjiangXu/AS03_06 | AS03-06: Gene expression of protein import / the cardiolipin pathway / HTRA2 / MTCH2 in AMLs]] * [[CancerStemCellProject/ChangjiangXu/AS04_import_proteins_Danny | AS04_import_proteins_Danny: Gene expression of the mitochondrial import proteins MPPbeta in AML and HSC]] * Laurie Ailles * [[CancerStemCellProject/ChangjiangXu/LA02 | LA02 (LA02_CAF_ovarian_Laurie): Crosstalk between CAFs and ovarian cancer cells]] 1. [[CancerStemCellProject/ChangjiangXu/LA02#Differential_Expression_Analysis | Differential expression analysis]] 1. [[CancerStemCellProject/ChangjiangXu/LA02#TCGA_OV_Data_Analysis | TCGA OV data analysis]] * [[CancerStemCellProject/ChangjiangXu/LA03 | LA03 (LA03_part3_CAF_H&N_Keira): Crosstalk between CAFs and epithelial cancer cells in the Head and Neck cancer]] * Peter Dirks |
Line 18: | Line 23: |
* [[CancerStemCellProject/ChangjiangXu/CG04 | Cyndi Guidos]] * [[CancerStemCellProject/ChangjiangXu/oPOSSUM | oPOSSUM]] * HALT02/JAK2 * [[CancerStemCellProject/ChangjiangXu/HALT02_SRC | Differential expression analysis of SRC high vs low (negative) sub-populations]] * [[CancerStemCellProject/ChangjiangXu/HALT02_JAK2 | Comparison of the pathways for XG-R/PF-R, XG-NR/PF-NR, and XG-R/PF-NR]] |
1. [[CancerStemCellProject/ChangjiangXu/PD03#PD03-part2:_Normal_Cells | Part2: normal cells]] 1. [[CancerStemCellProject/ChangjiangXu/PD03#PD03-part3:_TCGA_Glioblastoma_Data_Analysis | Part3: TCGA GBM data analysis]] 1. [[CancerStemCellProject/ChangjiangXu/PD03#Comparison_of_TCGA_GBM_Affymetrix_and_RNAseq_Data | Comparison of TCGA GBM Affymetrix and RNAseq data]] * John Dick * HALT02/JAK2 1. [[CancerStemCellProject/ChangjiangXu/HALT02_SRC | Differential expression analysis of SRC high vs low (negative) sub-populations]] 1. [[CancerStemCellProject/ChangjiangXu/HALT02_JAK2 | Comparison of the pathways for XG-R/PF-R, XG-NR/PF-NR, and XG-R/PF-NR]] * [[CancerStemCellProject/ChangjiangXu/JD12_relapsedAML | JD12_relapsedAML_Liran: Clustering and pathway analysis of patients with relapsed AML]] * [[CancerStemCellProject/ChangjiangXu/JD13_Itgb7_Peter | JD13_Itgb7_Peter: ITGb7+ and ITGb7– hematopoietic stem cells]] * [[CancerStemCellProject/ChangjiangXu/JD14_Sasan_FL_BM | JD14_Sasan_FL_BM: Differential expression analysis and gene-set enrichment analysis on hematopoietic stem cells derived from bone marrow or fetal liver]] |
Line 26: | Line 36: |
* [[CancerStemCellProject/ChangjiangXu/CG04 | Cyndi Guidos]] * [[CancerStemCellProject/ChangjiangXu/oPOSSUM | oPOSSUM]] |
|
Line 32: | Line 45: |
1. [[CSCBiostatService/survivalAnalysis | Survival analysis]] |
OICR Cancer Stem Cell Program
Experimental Design and Statistical Analysis
- OICR CSC Projects: Biostatistical Part (PI's name and/or project title listed below)
- Aaron Schimmer
- Laurie Ailles
- Peter Dirks
- John Dick
- Bret Pearson